NCT00436930View on ClinicalTrials.gov

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

autologous tumor cell vaccine

Given subcutaneously

BIOLOGICAL

sargramostim

Given subcutaneously

BIOLOGICAL

therapeutic autologous dendritic cells

Given subcutaneously

Trial Locations (1)

92663

Hoag Cancer Institute at Hoag Memorial Hospital Presbyterian, Newport Beach

All Listed Sponsors
lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00436930 - Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma | Biotech Hunter | Biotech Hunter